Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847287 · ClinicalTrials.gov registry record
A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 60
- Enrollment target
NCT01847287: Completed study, sponsored by University at Buffalo.
NCT01847287 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01847287 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The primary aim of this study is to evaluate the effect of using Tysabri on changes in the brain using MRI and on disease progression in patients with relapsing-remitting Multiple Sclerosis over 5 years.
Primary Outcome
Evaluation of MRI images from baseline in comparison with a 5 year MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-02 |
What the finished NCT01847287 record still lists
NCT01847287 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01847287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01847287 about?
NCT01847287 is a clinical study titled "A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years". The primary aim of this study is to evaluate the effect of using Tysabri on changes in the brain using MRI and on disease progression in patients with relapsing-remitting Multiple Sclerosis over 5 years.
What is the current status of trial NCT01847287?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-05. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01847287?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia